Effects of biological therapies on chronic rhinosinusitis in severe asthmatic patients

OBJECTIVE: The introduction of monoclonal antibody (mAb) therapies represents a promising treatment for refractory chronic rhinosinusitis (CRS). We assessed the effects of selected mAbs (omalizumab, mepolizumab, benralizumab) on CRS in severe asthmatic patients in a real-life setting. METHODS: A pro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Acta Otorhinolaryngol Ital
Autors principals: Bandi, Francesco, Gallo, Stefania, Preti, Andrea, Mozzanica, Francesco, Visca, Dina, Marelli, Margherita, Maddalone, Enrico, Gambarini, Cinzia, Vaghi, Adriano, Spanevello, Antonio, Castelnuovo, Paolo
Format: Artigo
Idioma:Inglês
Publicat: Pacini Editore Srl 2021
Matèries:
Rhinology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7889250/
https://ncbi.nlm.nih.gov/pubmed/33558772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14639/0392-100X-N0716
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars